Sir,

A 54-year-old Chinese male presented with a 2-month history of recurrent fever and 1-month history of multiple enlarged superficial lymph nodes. He was admitted in our hospital on December 9, 2016. The history of the patient was not remarkable except that he had consumed bamboo rats a year ago. Physical examination showed enlarged left cervical, bilateral retroauricular, supraclavicular, and inguinal lymph nodes. He subsequently developed skin lesions which showed painful erythematous papules, plaques, pustules, and edematous erythema over the face, dorsa of hands, and lower extremities \[Figure [1a](#F1){ref-type="fig"}--[c](#F1){ref-type="fig"}\]. The skin lesions progressed into erythema, blisters, and pustules distributed over the face and purple-red plaques and pustules distributed over the hands and lower extremities on December 14, 2016. Relevant investigations were carried out; meanwhile, treatment with fluconazole (0.2 g daily for 2 weeks) and levofloxacin (0.2 g b.i.d. during hospitalization) was started. Subsequently, methylprednisolone 40 mg/day was added to the therapeutic regimen and tapered over 2 weeks along with thalidomide (50 mg t.d.s. for 1 week). The skin lesions resolved gradually; however, a new painful nodule appeared on left underjaw on December 23, 2016 \[[Figure 1d](#F1){ref-type="fig"}\]. Amphotericin B 10 mg/day was given at an incremental dose of 10 mg/day until 50 mg/day. After that, the dose was maintained. At the same time, fluconazole was replaced with itraconazole 0.2 g b.i.d. With modification to the treatment regimen, the skin lesions improved gradually and the patient was better. However, recurrent fever and enlarging cervical lymph nodes developed with swelling and flush over the neck on February 10, 2017. The clinical symptoms improved when therapeutic regimen was modified (levofloxacin was replaced with clarithromycin 0.5 g/day).

![Clinical manifestations. Painful erythematous plaques, papules, and edematous erythema with pustules within lesions appeared on (a) the face, (b) extensor of hands, and (c) lower extremities; (d) a newly painful nodule appeared under left underjaw](IJD-63-428-g001){#F1}

Blood test showed leukocyte count 29.08 × 10^9^/L, neutrophilic granulocyte percentage 80.8%, erythrocyte sedimentation rate 108 mm/h, and C-reactive protein 118.83 mg/L. Test for anti-HIV was negative, but anti-interferon gamma (IFN-γ) autoantibodies were positive. Biopsy of bone marrow revealed no abnormal features. Cultures of blood and sputum were negative for fungi and bacteria. Histopathologically, biopsy of skin lesion taken from the left side of the face showed papillary dermal edema and extensive infiltration of neutrophils into the dermis \[[Figure 2a](#F2){ref-type="fig"}, the biopsy was done on December 15, 2016\]. The histopathological manifestation was consistent with Sweet\'s syndrome (SS). Histopathological examination of lymph node taken from right groin revealed yeast-like organisms under microscope \[[Figure 2b](#F2){ref-type="fig"}, the biopsy was done on December 16, 2016\]. Biopsy of the nodular lesion on the left underjaw showed both yeast-like organisms and acid-fast rods under microscope \[Figure [2c](#F2){ref-type="fig"} and [d](#F2){ref-type="fig"}, the biopsy was done on December 23, 2016\]. The DNA capacity of *Talaromyces marneffei* in the enlarged lymph node was 23.44 copies/μl, but those could not be detected in the whole blood and the nodular lesion from left underjaw (data were provided by the research group of Cao Cunwei). This result supported the diagnosis of deep mycosis caused by *T. marneffei*. Subsequently, culture of material from left underjaw lesion was negative for *T. marneffei* but positive for mycobacteria \[Figure [3a](#F3){ref-type="fig"}--[c](#F3){ref-type="fig"}\]. The type of mycobacteria was identified as *Mycobacterium abscessus* by mass spectrometric technique and molecular identification.

![Histopathology findings. (a) Papillary dermal edema, extensive infiltration of neutrophils into the dermis without leukocytoclastic vasculitis (H and E, ×100); (b and c) Yeast-like organisms with binary fission (arrows), (PAS, ×400); (d) ingestion of Mycobacterium cells (arrow) in multinucleated giant cell (Ziehl--Neelsen, ×1000)](IJD-63-428-g002){#F2}

![Culture of skin lesion. (a) Colonies on brain heart infusion media appeared smooth or rough, white or grayish; (b) Mycobacterium cells were Gram-positive (Gram, ×1000); (c) Mycobacterium cells appeared acid-fast rods. (Ziehl--Neelsen, ×1000)](IJD-63-428-g003){#F3}

The patient was diagnosed as SS with *T. marneffei* and *M. abscessus* infections due to anti-IFN-γ autoantibodies. According to our practice, low-dose corticosteroid treatment for a short time was good at reducing the aseptic inflammatory reaction in SS caused by the pathogens. Thalidomide was used in the treatment to reduce the dose of corticosteroid gradually. Then, the effect of antimicrobial agents produced excellent results, as the clinical symptoms of our patient improved gradually. After hospital discharge, he remained well with the administration of long-term antimicrobial therapy at the follow-up so far.

To the best of our knowledge, similar cases were rarely reported in the literatures.\[[@ref1][@ref2]\] Moreover, this was the first reported case of a patient developed SS associated with *T. marneffei* and *M. abscessus* infection due to anti-IFN-γ autoantibodies.

Chan *et al*.\[[@ref1]\] reported a 57-year-old Chinese male with anti-IFN-γ autoantibodies positivity developed SS with *T. marneffei* infection. The hallmark edema in SS was not seen in that case but was present in our case. SS was described as a kind of reactive dermatosis in patients with nontubercular mycobacterial infection.\[[@ref3][@ref4]\] Though neutrophilic infiltration was present in the dermis in the case reported by Liu *et al*.\[[@ref3]\] but dermal edema was absent. The phenomenon of absent edema in histopathological examination of SS in these reported cases was interesting. We speculate that it might be associated with varied virulence of pathogens and varied immune status of patients. There was limited knowledge to clarify this interesting phenomenon, especially in patients with deficiency of anti-IFN-γ autoantibodies.
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